About
Our Story
We provide information, education, facilitation, and access to advanced stem cell treatments. We act as sponsor, with Dr. Levy serving as Chair and Study Director, for clinical trials and treatments involving bone marrow-derived stem cells in ophthalmic and neurologic disease.
Our Vision
Many diseases and injuries have no current medical approaches capable of restoring lost function. For many patients, their first encounter with a disease or injury brings the difficult realization that, despite major advances in some areas, the medical and pharmaceutical communities offer them limited options.
By focusing on clinical and translational research, we have developed new and innovative methods aimed at improving vision impaired by disease and helping patients affected by a range of neurologic conditions.
We are committed to treating patients within the framework of clinical studies and publishing our results to help shift the standard of care. Patients considering participation in our trials must understand that individual outcomes cannot be predicted. Even in conditions where we have demonstrated statistically significant benefits, results cannot be guaranteed for each patient.
Our Technology
Stem cells represent a new and innovative approach to treatment. Research has demonstrated that these cells have the potential to help form and repair tissues throughout the body. We are firmly committed to using bone marrow-derived stem cells, which we believe offer clear advantages over other types—most notably, a 30-fold greater ability to pass through the lungs and reach the brain, eyes, and spinal cord via the capillary beds.
While the pharmaceutical industry continues to pursue the development of cell-based products, we believe that tapping into the body’s natural repair systems can already deliver significant therapeutic benefits.
